This job listing has expired and the position may no longer be open for hire.

(Oncology) USMA Medical Director- Niraparib at GlaxoSmithKline

Posted in Science 30+ days ago.

This job brought to you by eQuest

Type: Full-Time
Location: Philadelphia, Pennsylvania

Job Description:

Are you at a crossroad in your career ....not feeling valued, motivated or able to stand out ? This highly visible medical affairs role will allow you to shape and execute the brand medical strategy, while engaging with a broad range of highly specialized experts and could be an ideal opportunity to explore..

GSK’s Pharmaceutical Medicines business:

Our pharmaceutical medicines business has a broad portfolio of innovative and established medicines.  Currently, we are focusing on developing new medicines in Oncology, Immuno-Inflammation, Respiratory, and HIV/Infectious Diseases. The rebuilding of our Pharmaceuticals pipeline continues with most of our new medicines in development targeting modulation of the immune system. Major progress has been made in our immuno-oncology pipeline with assets now in clinical development, reflecting organic progression, our recent acquisition of Tesaro, Inc., and our new global strategic alliance with Merck KGaA, also known as EMD Serono in the U.S.

GSK Oncology R&D is focused on building industry-leading portfolios in three cutting-edge areas of science:

  • Invest to develop differentiated assets and combinations in increasingly crowded IO space.

  • Cancer Epigenetics: Take a more focused approach, pruning some existing assets while maintaining efforts in discovery and clinical development of most promising programs

  • Cell Therapy (CGT): Utilize competitive platform play based on patented technology

Acquisition of Tesaro, Inc.

GSK’s acquisition of Tesaro, Inc. an oncology-focused company based in Waltham, Massachusetts, significantly strengthens our pharmaceuticals business through accelerating of GSK’s pipeline and commercial capability in oncology.  TESARO has a major marketed oncology product, Zejula (niraparib), an oral poly ADP ribose polymerase (PARP) inhibitor currently approved in the US and Europe as a treatment for adult patients with recurrent ovarian cancer.  PARP inhibitors are transforming the treatment of ovarian cancer, notably demonstrating marked clinical benefit in patients with or without germline mutations in a BRCA gene (gBRCA).GSK also believes that PARP inhibitors offer significant opportunities for use in the treatment of multiple cancer types, therefore Zejula is also being investigated for use as a possible treatment in lung, breast, and prostate cancer, both as a monotherapy and in combination with other medicines, including with TESARO’s own anti-PD-1 antibody (dostarlimab, formerly known as TSR-042).  In addition to Zejula and dostarlimab, TESARO has several other oncology assets in its pipeline, including antibodies directed against TIM-3 and LAG-3.

For more Information on GSK Oncology, please visit:


Our medical affairs physicians and scientists are the experts on our medicines/vaccines and an extremely valuable part of our global business. In all countries where our medicines and vaccines are marketed, these professionals help to ensure that healthcare professionals can understand the appropriate use of our products and ensure that the patient remains at the heart of our decision making.  Our Global Medical organization, under the leadership of Sabine Luik, SVP-Global Medical & Regulatory Affairs and Chief Medical Officer, is at the forefront of the industry-leading changes to improve patient treatment options.  We are committed to making GSK’s Medical Affairs team the best in our industry, and a trusted valued partner in the delivery of healthcare to patients

The Medical Director is accountable for the work of US Medical Affairs for a specific medicine(s) in partnership with the Global Franchise, R&D, US medical matrix team(s) and US medical commercial strategy team(s).  The incumbent should be able to contribute to the development and execution of the US Medical Affairs Plan and the medical sections for the strategic plan for one or more medicines integrating US environment and medical voice of customer (patients, providers, payers) into medical affairs strategy.  In addition, the candidate must ensure US needs for medical and health outcomes evidence generation are represented and incorporated into the global medical work and recommend scientifically appropriate measures within health outcomes research over the life cycle of the medicine(s) to meet US reimbursement needs.


  • Ensure US external experts are appropriately engaged over the life cycle of the medicine in close collaboration with the field medical organization to gain insights into our medicine(s) and diseases through advisory boards, consultations, scientific meetings, publications and research related activities.

  • Provide input to the global Integrated Evidence Plan for the medicine(s) and should be able to lead the design and delivery of US-focused late phase studies in collaboration with the Global Franchises, act as medical monitor when appropriate and manage US funded investigator sponsored studies.

  • Partner with stakeholders to ensure delivery of all assigned medical activities to support life cycle management, ensuring integrity of scientific content and sound medical governance.

  • Work closely with R&D, Global Franchise, safety, regulatory, and manufacturing to ensure appropriate decisions based on a benefit-risk assessment.

  • Serve as the US Medical Affairs point of contact for safety issues and contribute to the copy approval process.

  • Approximately 20% travel, mostly domestic, may be required.


Why you?

Basic Qualifications:

We are looking for professionals with these required skills to achieve our goals:

  • Physician (M.D. or equivalent) with demonstrated interest and experience in Oncology. Active or eligibility for a US Medical license (or equivalent previously outside of the US) is required. 

  • In-depth knowledge of Oncology especially related to disease mechanisms, patient care, treatment options, clinical decision making, and key issues and advances in the field.

  • Familiarity with the key medical/scientific experts in the Oncology field with the capability of effectively interacting and/or collaborating with the experts.

  • Effective team leadership, with proven ability to motivate, influence, negotiate, and collaborate; strong project management skills; solid planning and organizational skills; strong scientific/analytical problem-solving skills.

  • Strong business acumen and communication skills (oral and written), including the ability to identify and articulate the value of clinical and heath outcome data to internal stakeholders and external customers.

  • Product life cycle management experience, including the ability to detect and foresee potential changes in the healthcare, regulatory and competitive environments throughout the product lifespan; to understand the impact of new data on the value / positioning of products in guidelines / formularies; and to proactively identify unmet needs and how to address them.

  • Robust knowledge of the US healthcare environment including disease-specific research priorities, public health need, competitor landscape, clinical practice trends and treatment guidelines evolution.

  • Clinical research/drug development experience obtained while working in the pharmaceutical industry or substantial clinical trial experience collaborating with pharmaceutical sponsors in either the academic or clinical practice setting is preferred.

  • Knowledge and experience in late phase trials and solid knowledge of drug development and FDA guidance to industry.

  • Teaching skills.  The candidate is expected to become the educator-in-chief on his/her medicine within the US Medical Affairs group.

Preferred Qualifications:

If you have the following characteristics, it would be a plus:

  • Board certification in Oncology is preferred 

  • Medical affairs experience is preferred.

Why GSK?

Our values and expectations are at the heart of everything we do and form an important part of our culture.

These include Patient focus, Transparency, Respect, Integrity along with Courage, Accountability, Development, and Teamwork. As GSK focuses on our values and expectations and a culture of innovation, performance, and trust, the successful candidate will demonstrate the following capabilities:

  • Agile and distributed decision-making – using evidence and applying judgement to balance pace, rigour and risk, governance and control, managing ambiguity and paradox.

  • Managing individual performance.

  • Creating a performance culture and driving results, prioritisation, execution, delivering performance.

  • Setting strategic direction and leading on-going organisational transformation.

  • Building a resilient organisation.

  • Building strong relationships and collaboration in service of common goals, engaging the organisation and building trusted external networks for mutual benefit.

  • Managing P&L and capital allocation.

If you require an accommodation or other assistance to apply for a job at GSK, please contact the GSK HR Service Centre at 1-877-694-7547 (US Toll Free) or +1 801 567 5155 (outside US).

GSK is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive equal consideration for employment without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit GSK’s Transparency Reporting For the Record site.